A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...

随着研究的不断深入和治疗经验的积累，免疫治疗、靶向治疗与化疗的多种联合方案在恶性肿瘤治疗中取得了显著进展，极大地丰富了多种恶性肿瘤的治疗模式。目前，针对晚期BTC方面的联合治疗方案也在如火如荼地进行中，并已取得一系列令人振奋的研究结果，有望为更多BTC患者带来生存希望。

Henlius (2696.HK) held its 2025 Global R&D Day under the theme of 'Collaborate to Create'. Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across ...

随着众多mRNA新冠疫苗在控制全球疫情方面发挥巨大作用，mRNA技术也在全球引起越来越多的关注。同时应用mRNA疫苗技术研发新型治疗性和预防性肿瘤疫苗，也为肿瘤治疗带来了新的机会。虽然目前还没有临床上市的mRNA肿瘤疫苗，但是许多制药企业已经开展了肿瘤疫苗研发管线，相当一部分产品已进入I期和II期临床试验阶段。

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Ruffini教授：这一问题在近年学术会议中经常被讨论，2025 ...

MELBOURNE, Australia and INDIANAPOLIS, IN, USA I April 16, 2025 I Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces ...